Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

A membership categorization analysis of roles, activities and relationships in inclusive research conducted by co-researchers with intellectual disabilities.

Frankena TK, Naaldenberg J, Tobi H, van der Cruijsen A, Jansen H, van Schrojenstein Lantman-de Valk H, Leusink G, Cardol M.

J Appl Res Intellect Disabil. 2019 May;32(3):719-729. doi: 10.1111/jar.12567. Epub 2019 Feb 22.

PMID:
30793817
2.

Health problems of people with intellectual disabilities in Dutch out-of-hours primary care.

Heutmekers M, Naaldenberg J, Verheggen SA, Assendelft WJJ, van Schrojenstein Lantman-de Valk HMJ, Tobi H, Leusink GL.

J Appl Res Intellect Disabil. 2019 Mar;32(2):475-481. doi: 10.1111/jar.12537. Epub 2018 Oct 23.

PMID:
30353621
3.

Self-reported measures in health research for people with intellectual disabilities: an inclusive pilot study on suitability and reliability.

Vlot-van Anrooij K, Tobi H, Hilgenkamp TIM, Leusink GL, Naaldenberg J.

BMC Med Res Methodol. 2018 Jul 16;18(1):80. doi: 10.1186/s12874-018-0539-1.

4.

Research design: the methodology for interdisciplinary research framework.

Tobi H, Kampen JK.

Qual Quant. 2018;52(3):1209-1225. doi: 10.1007/s11135-017-0513-8. Epub 2017 Apr 27.

5.
6.

Priority-setting and feasibility of health information exchange for primary care patients with intellectual disabilities: A modified Delphi study.

Mastebroek M, Naaldenberg J, Tobi H, van Schrojenstein Lantman-de Valk HMJ, Lagro-Janssen ALM, Leusink GL.

Patient Educ Couns. 2017 Oct;100(10):1842-1851. doi: 10.1016/j.pec.2017.04.010. Epub 2017 Apr 15.

PMID:
28515025
7.

Meet meat: An explorative study on meat and cultured meat as seen by Chinese, Ethiopians and Dutch.

Bekker GA, Tobi H, Fischer ARH.

Appetite. 2017 Jul 1;114:82-92. doi: 10.1016/j.appet.2017.03.009. Epub 2017 Mar 16.

PMID:
28323057
8.

Explicit and implicit attitude toward an emerging food technology: The case of cultured meat.

Bekker GA, Fischer ARH, Tobi H, van Trijp HCM.

Appetite. 2017 Jan 1;108:245-254. doi: 10.1016/j.appet.2016.10.002. Epub 2016 Oct 4.

PMID:
27717657
9.
10.

Editorial: Health inequity: from evidence to action.

Linehan C, Naaldenberg J, van Schrojenstein Lantman de Valk H, Tobi H.

J Appl Res Intellect Disabil. 2015 Jan;28(1):1-2. doi: 10.1111/jar.12136. No abstract available.

PMID:
25530569
11.

Psychometric properties of the OLQ-13 scale to measure Sense of Coherence in a community-dwelling older population.

Naaldenberg J, Tobi H, van den Esker F, Vaandrager L.

Health Qual Life Outcomes. 2011 May 23;9:37. doi: 10.1186/1477-7525-9-37.

12.

Interdisciplinary thinking in agricultural and life sciences higher education.

Spelt EJ, Biemans HJ, Luning PA, Tobi H, Mulder M.

Commun Agric Appl Biol Sci. 2010;75(1):73-9.

PMID:
20491398
13.

Day care at green care farms: a novel way to stimulate dietary intake of community-dwelling older people with dementia?

De Bruin SR, Oosting SJ, Tobi H, Blauw YH, Schols JM, De Groot CP.

J Nutr Health Aging. 2010 May;14(5):352-7.

PMID:
20424801
14.

Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands.

Faber A, Kalverdijk LJ, de Jong-van den Berg LT, Hugtenburg JG, Minderaa RB, Tobi H.

Eur Child Adolesc Psychiatry. 2010 Feb;19(2):159-66. doi: 10.1007/s00787-009-0075-y. Epub 2009 Nov 6.

15.

Current issues around the pharmacotherapy of ADHD in children and adults.

Meijer WM, Faber A, van den Ban E, Tobi H.

Pharm World Sci. 2009 Oct;31(5):509-516. doi: 10.1007/s11096-009-9302-3. Epub 2009 Jun 27. Review.

16.

Longitudinal changes in GPs' task perceptions, self-efficacy, barriers and practices of nutrition education and treatment of overweight.

Visser F, Hiddink G, Koelen M, van Binsbergen J, Tobi H, van Woerkum C.

Fam Pract. 2008 Dec;25 Suppl 1:i105-11. doi: 10.1093/fampra/cmn078.

PMID:
19112085
17.

Use of antipsychotic drugs among Dutch youths between 1997 and 2005.

Kalverdijk LJ, Tobi H, van den Berg PB, Buiskool J, Wagenaar L, Minderaa RB, de Jong-van den Berg LT.

Psychiatr Serv. 2008 May;59(5):554-60. doi: 10.1176/ps.2008.59.5.554.

PMID:
18451016
18.
19.

Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.

de Bildt A, Mulder EJ, Scheers T, Minderaa RB, Tobi H.

Pediatrics. 2006 Dec;118(6):e1860-6.

PMID:
17142506
20.

Use of double-blind placebo-controlled N-of-1 trials among stimulant-treated youths in The Netherlands: a descriptive study.

Faber A, Keizer RJ, van den Berg PB, de Jong-van den Berg LT, Tobi H.

Eur J Clin Pharmacol. 2007 Jan;63(1):57-63. Epub 2006 Nov 18.

PMID:
17115147
21.

Studying co-medication patterns: the impact of definitions.

Tobi H, Faber A, van den Berg PB, Drane JW, de Jong-van den Berg LT.

Pharmacoepidemiol Drug Saf. 2007 Apr;16(4):405-11.

PMID:
16981229
22.

Parents report on stimulant-treated children in the Netherlands: initiation of treatment and follow-up care.

Faber A, Kalverdijk LJ, de Jong-van den Berg LT, Hugtenburg JG, Minderaa RB, Tobi H.

J Child Adolesc Psychopharmacol. 2006 Aug;16(4):432-40.

PMID:
16958568
23.

Prescribed doses of inhaled steroids in Dutch children: too little or too much, for too short a time.

Schirm E, de Vries TW, Tobi H, van den Berg PB, de Jong-van den Berg LT.

Br J Clin Pharmacol. 2006 Oct;62(4):383-90. Epub 2006 Jun 23.

24.

Antidepressant prevalence for youths: a multi-national comparison.

Zito JM, Tobi H, de Jong-van den Berg LT, Fegert JM, Safer DJ, Janhsen K, Hansen DG, Gardner JF, Glaeske G.

Pharmacoepidemiol Drug Saf. 2006 Nov;15(11):793-8.

PMID:
16715536
25.

The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands.

de Vries TW, Tobi H, Schirm E, van den Berg P, Duiverman EJ, de Jong-van den Berg LT.

Eur J Clin Pharmacol. 2006 Jan;62(1):51-5. Epub 2005 Dec 20.

PMID:
16365748
26.

Complex pharmaceutical care intervention in pulmonary care: part B. Patient opinion and process survey.

Stuurman-Bieze AG, Kokenberg ME, Tobi H, de Boer WO, van Doormaal JE, Jong-van den de Berg LT, Tromp TF.

Pharm World Sci. 2005 Oct;27(5):385-92.

PMID:
16341745
27.

Recruitment of parents and physicians of stimulant-using children via community pharmacies is successful.

Faber A, de Jong-van den Berg L, Netjes K, Kalverdijk L, Minderaa R, Tobi H.

J Clin Epidemiol. 2005 Oct;58(10):1072-3. No abstract available.

PMID:
16168354
28.

Leflunomide in the treatment of rheumatoid arthritis. An analysis of predictors for treatment continuation.

van Roon EN, Hoekstra M, Tobi H, Jansen TL, Bernelot Moens HJ, Brouwers JR, van de Laar MA.

Br J Clin Pharmacol. 2005 Sep;60(3):319-25.

29.

Drug utilisation by children and adolescents with mental retardation: a population study.

Tobi H, Scheers T, Netjes KA, Mulder EJ, de Bildt A, Minderaa RB.

Eur J Clin Pharmacol. 2005 Jun;61(4):297-302. Epub 2005 May 20.

PMID:
15906017
30.

Sex differences in concomitant medication with benzodiazepines or antidepressants in first-break schizophrenic patients treated with antipsychotic medication.

Rijcken CA, Knegtering H, Bruggeman R, Tobi H, de Jong-van den Berg LT.

Psychiatry Res. 2005 Apr 15;134(2):143-50.

PMID:
15840415
31.

Psychotropic co-medication among stimulant-treated children in The Netherlands.

Faber A, de Jong-van den Berg LT, van den Berg PB, Tobi H.

J Child Adolesc Psychopharmacol. 2005 Feb;15(1):38-43.

PMID:
15741784
32.

Small proportions: what to report for confidence intervals?

Tobi H, van den Berg PB, de Jong-van den Berg LT.

Pharmacoepidemiol Drug Saf. 2005 Apr;14(4):239-47. Erratum in: Pharmacoepidemiol Drug Saf. 2006 Mar;15(3):211.

PMID:
15719354
33.

[Use of oral contraceptives in the years 1994-2002: different but not less].

Vroom F, de Jong PH, van den Berg PB, Tobi H, de Jong-van den Berg LT.

Ned Tijdschr Geneeskd. 2005 Jan 1;149(1):23-8. Dutch.

PMID:
15651500
34.

Drug use among fathers around time of conception: two register based surveys from Denmark and The Netherlands.

Schirm E, Pedersen L, Tobi H, Nielsen GL, Sørensen HT, de Jong-van den Berg LT.

Pharmacoepidemiol Drug Saf. 2004 Sep;13(9):609-13.

PMID:
15362083
35.

Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children.

Schirm E, Tobi H, de Jong-van den Berg LT.

J Clin Epidemiol. 2004 Jul;57(7):737-41.

PMID:
15358402
36.

Does uncollected medication reduce the validity of pharmacy dispensing data?

Tobi H, van den Heuvel NJ, de Jong-van den Berg LT.

Pharmacoepidemiol Drug Saf. 2004 Jul;13(7):497-500.

PMID:
15269934
37.

Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.

Van Roon EN, Jansen TL, Mourad L, Houtman PM, Bruyn GA, Griep EN, Wilffert B, Tobi H, Brouwers JR.

Br J Clin Pharmacol. 2004 Aug;58(2):201-8.

38.

Refill rate of antipsychotic drugs: an easy and inexpensive method to monitor patients' compliance by using computerised pharmacy data.

Rijcken CA, Tobi H, Vergouwen AC, de Jong-van den Berg LT.

Pharmacoepidemiol Drug Saf. 2004 Jun;13(6):365-70.

PMID:
15170765
39.

Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.

Van Roon EN, Jansen TL, Mourad L, Houtman PM, Bruyn GA, Griep EN, Wilffert B, Tobi H, Brouwers JR.

Br J Clin Pharmacol. 2004 Jun;57(6):790-7.

40.

Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system.

Schirm E, Meijer WM, Tobi H, de Jong-van den Berg LT.

Eur J Obstet Gynecol Reprod Biol. 2004 Jun 15;114(2):182-8.

PMID:
15140513
41.

How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information.

Schirm E, Monster TB, de Vries R, van den Berg PB, de Jong-van den Berg LT, Tobi H.

Pharmacoepidemiol Drug Saf. 2004 Mar;13(3):173-9.

PMID:
15072117
42.

Reported adverse drug reactions and their determinants in Dutch children outside the hospital.

Schirm E, Tobi H, van Puijenbroek EP, Monster-Simons MH, de Jong-van den Berg LT.

Pharmacoepidemiol Drug Saf. 2004 Mar;13(3):159-65.

PMID:
15072115
43.

Lack of appropriate formulations of medicines for children in the community.

Schirm E, Tobi H, de Vries TW, Choonara I, De Jong-van den Berg LT.

Acta Paediatr. 2003 Dec;92(12):1486-9.

PMID:
14971804
44.

Drug use during breastfeeding. A survey from the Netherlands.

Schirm E, Schwagermann MP, Tobi H, de Jong-van den Berg LT.

Eur J Clin Nutr. 2004 Feb;58(2):386-90.

PMID:
14749761
45.

Socio-economic differences in prescription and OTC drug use in Dutch adolescents.

Tobi H, Meijer WM, Tuinstra J, de Jong-van den Berg LT.

Pharm World Sci. 2003 Oct;25(5):203-6.

PMID:
14584226
46.

[Hormone replacement therapy in the peri-menopausal and post menopausal period: more than half of the women were treated for more than one year].

Tobi H, van den Berg PB, Brouwers JR, de Jong-van den Berg LT.

Ned Tijdschr Geneeskd. 2003 Sep 20;147(38):1853-5. Dutch.

PMID:
14533498
47.

Combined use of SSRIs and NSAIDs increases the risk of gastrointestinal adverse effects.

de Jong JC, van den Berg PB, Tobi H, de Jong-van den Berg LT.

Br J Clin Pharmacol. 2003 Jun;55(6):591-5.

48.

Risk factors for unlicensed and off-label drug use in children outside the hospital.

Schirm E, Tobi H, de Jong-van den Berg LT.

Pediatrics. 2003 Feb;111(2):291-5.

PMID:
12563053
49.

Influence of the third generation pill controversy on prescriptions for oral contraceptives among first time users: population based study.

de Jong-van den Berg L, Tobi H, Bijker B, van den Berg P.

BMJ. 2003 Feb 1;326(7383):254. No abstract available.

50.

Relationship between pharmacokinetics of 5-FU in plasma and in saliva, and toxicity of 5-fluorouracil/folinic acid.

Jansman FG, Coenen JL, De Graaf JC, Tobi H, Sleijfer DT, Brouwers JR.

Anticancer Res. 2002 Nov-Dec;22(6B):3449-55.

PMID:
12552938

Supplemental Content

Support Center